HEADER TRANSFERASE 08-FEB-23 7FU1 TITLE CRYSTAL STRUCTURE OF HUMAN CYCLIC GMP-AMP SYNTHASE IN COMPLEX WITH 5- TITLE 2 [3-[[(5-BROMO-2-HYDROXYBENZOYL)AMINO]METHYL]PHENYL]-2-METHYLPYRAZOLE- TITLE 3 3-CARBOXYLIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIC GMP-AMP SYNTHASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 161-522; COMPND 5 SYNONYM: CGAMP SYNTHASE,CGAS,H-CGAS,2'3'-CGAMP SYNTHASE,MAB-21 COMPND 6 DOMAIN-CONTAINING PROTEIN 1; COMPND 7 EC: 2.7.7.86; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CGAS, C6ORF150, MB21D1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21A_CGAS(161-522_WT) KEYWDS IMMUNE RESPONSE, TRANSFERASE, NTASE, DNA SENSOR EXPDTA X-RAY DIFFRACTION AUTHOR L.LEIBROCK,J.BENZ,K.GROEBKE-ZBINDEN,M.G.RUDOLPH REVDAT 1 21-FEB-24 7FU1 0 JRNL AUTH K.GROEBKE-ZBINDEN,A.VANDEMEULEBROUCKE,M.HILBERT,M.G.RUDOLPH JRNL TITL CRYSTAL STRUCTURE OF A HUMAN CYCLIC GMP-AMP SYNTHASE COMPLEX JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.07 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3260 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.07 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.53 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 78.7 REMARK 3 NUMBER OF REFLECTIONS : 21670 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1117 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 59.5545 - 4.1479 0.99 3409 204 0.1734 0.2107 REMARK 3 2 4.1479 - 3.2924 0.99 3276 168 0.2055 0.2877 REMARK 3 3 3.2924 - 2.8762 0.99 3250 156 0.2588 0.3403 REMARK 3 4 2.8762 - 2.6132 0.99 3222 169 0.2970 0.3199 REMARK 3 5 2.6132 - 2.4259 0.98 3154 182 0.3075 0.3996 REMARK 3 6 2.4259 - 2.2829 0.83 2667 150 0.3069 0.3156 REMARK 3 7 2.2829 - 2.1686 0.40 1262 75 0.4329 0.6503 REMARK 3 8 2.1686 - 2.0742 0.10 313 13 0.3304 0.2992 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 38.530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 70.38 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 72.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 161 THROUGH 253 ) REMARK 3 ORIGIN FOR THE GROUP (A): 22.6653 5.6083 21.9237 REMARK 3 T TENSOR REMARK 3 T11: 0.4145 T22: 0.4442 REMARK 3 T33: 0.5156 T12: -0.0092 REMARK 3 T13: 0.0712 T23: 0.0327 REMARK 3 L TENSOR REMARK 3 L11: 2.1144 L22: 1.7422 REMARK 3 L33: 1.5830 L12: -0.8256 REMARK 3 L13: -0.5865 L23: -0.3513 REMARK 3 S TENSOR REMARK 3 S11: -0.3060 S12: -0.2898 S13: -0.7168 REMARK 3 S21: -0.1000 S22: 0.1366 S23: -0.0985 REMARK 3 S31: 0.0770 S32: 0.1274 S33: 0.1495 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 254 THROUGH 326 ) REMARK 3 ORIGIN FOR THE GROUP (A): 18.1072 -5.2999 27.5819 REMARK 3 T TENSOR REMARK 3 T11: 0.5969 T22: 0.5081 REMARK 3 T33: 0.8345 T12: 0.0445 REMARK 3 T13: 0.1438 T23: 0.2658 REMARK 3 L TENSOR REMARK 3 L11: 8.4571 L22: 5.1034 REMARK 3 L33: 4.1708 L12: 1.6089 REMARK 3 L13: 0.4390 L23: -1.1348 REMARK 3 S TENSOR REMARK 3 S11: 0.1938 S12: -1.1476 S13: -1.5631 REMARK 3 S21: 0.5267 S22: -0.1031 S23: 0.0602 REMARK 3 S31: 0.9049 S32: -0.0850 S33: -0.0645 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 327 THROUGH 520 ) REMARK 3 ORIGIN FOR THE GROUP (A): 15.1322 21.9780 20.2397 REMARK 3 T TENSOR REMARK 3 T11: 0.2941 T22: 0.2804 REMARK 3 T33: 0.2605 T12: 0.0684 REMARK 3 T13: 0.0186 T23: -0.0297 REMARK 3 L TENSOR REMARK 3 L11: 3.4322 L22: 2.3719 REMARK 3 L33: 4.2920 L12: 0.0893 REMARK 3 L13: -0.4452 L23: 0.4351 REMARK 3 S TENSOR REMARK 3 S11: 0.1120 S12: -0.2671 S13: 0.2702 REMARK 3 S21: 0.1923 S22: -0.0145 S23: 0.2291 REMARK 3 S31: -0.5500 S32: -0.3232 S33: -0.0770 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ORIENTATION OF METHYLPYRAZOLE BASED ON REMARK 3 ELECTRON DENSITY. OTHER ROTAMER ALSO POSSIBLE. REMARK 4 REMARK 4 7FU1 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-23. REMARK 100 THE DEPOSITION ID IS D_1001405346. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.000030 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27059 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.070 REMARK 200 RESOLUTION RANGE LOW (A) : 59.530 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 6.505 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.07 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.7 REMARK 200 DATA REDUNDANCY IN SHELL : 7.26 REMARK 200 R MERGE FOR SHELL (I) : 6.74300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.450 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INHOUSE MODEL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10-12 MG/ML PROTEIN IN 25 MM TRIS/HCL REMARK 280 PH7.5, 500MM NACL, 2MM TCEP, SUPPLEMENTED WITH 10X MOLAR EXCESS REMARK 280 OF LIGAND AND, IF NEEDED, WITH 10 MM MGCL2 AND 5MM ATP, THEN REMARK 280 MIXED 1:1 WITH RESERVOIR OF THE PROCOMPLEX SCREEN. SEVERAL REMARK 280 CONDITIONS RESULTED IN CRYSTALS., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 22.67750 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 81.29800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 22.67750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 81.29800 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 291 REMARK 465 LYS A 292 REMARK 465 LYS A 365 REMARK 465 GLU A 366 REMARK 465 GLY A 367 REMARK 465 ASN A 368 REMARK 465 GLY A 369 REMARK 465 PHE A 370 REMARK 465 GLN A 371 REMARK 465 GLU A 521 REMARK 465 PHE A 522 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 215 58.31 -98.91 REMARK 500 ARG A 246 -27.58 64.23 REMARK 500 ARG A 255 86.73 28.89 REMARK 500 ARG A 300 30.87 -89.92 REMARK 500 ARG A 302 -72.45 56.70 REMARK 500 SER A 313 -141.57 48.18 REMARK 500 SER A 345 156.41 95.96 REMARK 500 LYS A 362 170.22 175.94 REMARK 500 GLU A 373 61.67 -110.19 REMARK 500 ASN A 389 77.23 -154.55 REMARK 500 GLU A 402 45.10 -104.48 REMARK 500 LYS A 427 -159.45 -76.28 REMARK 500 PHE A 516 80.13 35.09 REMARK 500 PHE A 519 55.41 -96.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 601 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 390 NE2 REMARK 620 2 CYS A 396 SG 113.4 REMARK 620 3 CYS A 397 SG 103.4 123.0 REMARK 620 4 CYS A 404 SG 101.6 104.5 109.0 REMARK 620 N 1 2 3 DBREF 7FU1 A 161 522 UNP Q8N884 CGAS_HUMAN 161 522 SEQRES 1 A 362 GLY ALA SER LYS LEU ARG ALA VAL LEU GLU LYS LEU LYS SEQRES 2 A 362 LEU SER ARG ASP ASP ILE SER THR ALA ALA GLY MET VAL SEQRES 3 A 362 LYS GLY VAL VAL ASP HIS LEU LEU LEU ARG LEU LYS CYS SEQRES 4 A 362 ASP SER ALA PHE ARG GLY VAL GLY LEU LEU ASN THR GLY SEQRES 5 A 362 SER TYR TYR GLU HIS VAL LYS ILE SER ALA PRO ASN GLU SEQRES 6 A 362 PHE ASP VAL MET PHE LYS LEU GLU VAL PRO ARG ILE GLN SEQRES 7 A 362 LEU GLU GLU TYR SER ASN THR ARG ALA TYR TYR PHE VAL SEQRES 8 A 362 LYS PHE LYS ARG ASN PRO LYS GLU ASN PRO LEU SER GLN SEQRES 9 A 362 PHE LEU GLU GLY GLU ILE LEU SER ALA SER LYS MET LEU SEQRES 10 A 362 SER LYS PHE ARG LYS ILE ILE LYS GLU GLU ILE ASN ASP SEQRES 11 A 362 ILE LYS ASP THR ASP VAL ILE MET LYS ARG LYS ARG GLY SEQRES 12 A 362 GLY SER PRO ALA VAL THR LEU LEU ILE SER GLU LYS ILE SEQRES 13 A 362 SER VAL ASP ILE THR LEU ALA LEU GLU SER LYS SER SER SEQRES 14 A 362 TRP PRO ALA SER THR GLN GLU GLY LEU ARG ILE GLN ASN SEQRES 15 A 362 TRP LEU SER ALA LYS VAL ARG LYS GLN LEU ARG LEU LYS SEQRES 16 A 362 PRO PHE TYR LEU VAL PRO LYS HIS ALA LYS GLU GLY ASN SEQRES 17 A 362 GLY PHE GLN GLU GLU THR TRP ARG LEU SER PHE SER HIS SEQRES 18 A 362 ILE GLU LYS GLU ILE LEU ASN ASN HIS GLY LYS SER LYS SEQRES 19 A 362 THR CYS CYS GLU ASN LYS GLU GLU LYS CYS CYS ARG LYS SEQRES 20 A 362 ASP CYS LEU LYS LEU MET LYS TYR LEU LEU GLU GLN LEU SEQRES 21 A 362 LYS GLU ARG PHE LYS ASP LYS LYS HIS LEU ASP LYS PHE SEQRES 22 A 362 SER SER TYR HIS VAL LYS THR ALA PHE PHE HIS VAL CYS SEQRES 23 A 362 THR GLN ASN PRO GLN ASP SER GLN TRP ASP ARG LYS ASP SEQRES 24 A 362 LEU GLY LEU CYS PHE ASP ASN CYS VAL THR TYR PHE LEU SEQRES 25 A 362 GLN CYS LEU ARG THR GLU LYS LEU GLU ASN TYR PHE ILE SEQRES 26 A 362 PRO GLU PHE ASN LEU PHE SER SER ASN LEU ILE ASP LYS SEQRES 27 A 362 ARG SER LYS GLU PHE LEU THR LYS GLN ILE GLU TYR GLU SEQRES 28 A 362 ARG ASN ASN GLU PHE PRO VAL PHE ASP GLU PHE HET ZN A 601 1 HET YU2 A 602 27 HETNAM ZN ZINC ION HETNAM YU2 (3P)-3-{3-[(5-BROMO-2-HYDROXYBENZAMIDO)METHYL]PHENYL}- HETNAM 2 YU2 1-METHYL-1H-PYRAZOLE-5-CARBOXYLIC ACID FORMUL 2 ZN ZN 2+ FORMUL 3 YU2 C19 H16 BR N3 O4 FORMUL 4 HOH *55(H2 O) HELIX 1 AA1 ALA A 162 ASP A 178 1 17 HELIX 2 AA2 THR A 181 CYS A 199 1 19 HELIX 3 AA3 GLY A 212 GLU A 216 5 5 HELIX 4 AA4 ASN A 260 GLN A 264 5 5 HELIX 5 AA5 SER A 272 ILE A 288 1 17 HELIX 6 AA6 PRO A 331 GLN A 335 5 5 HELIX 7 AA7 SER A 345 ARG A 353 1 9 HELIX 8 AA8 PHE A 379 ASN A 388 1 10 HELIX 9 AA9 CYS A 405 PHE A 424 1 20 HELIX 10 AB1 SER A 434 ASN A 449 1 16 HELIX 11 AB2 GLN A 451 LYS A 458 5 8 HELIX 12 AB3 ASP A 459 GLU A 478 1 20 HELIX 13 AB4 ASP A 497 ASN A 513 1 17 SHEET 1 AA1 7 GLY A 207 LEU A 208 0 SHEET 2 AA1 7 GLU A 225 GLU A 233 -1 O LYS A 231 N GLY A 207 SHEET 3 AA1 7 ILE A 316 SER A 326 1 O SER A 317 N PHE A 226 SHEET 4 AA1 7 PHE A 357 PRO A 361 -1 O LEU A 359 N LEU A 324 SHEET 5 AA1 7 TRP A 375 SER A 378 -1 O ARG A 376 N VAL A 360 SHEET 6 AA1 7 TYR A 248 PHE A 253 -1 N TYR A 249 O TRP A 375 SHEET 7 AA1 7 ILE A 237 GLU A 241 -1 N GLN A 238 O LYS A 252 SHEET 1 AA2 5 GLY A 207 LEU A 208 0 SHEET 2 AA2 5 GLU A 225 GLU A 233 -1 O LYS A 231 N GLY A 207 SHEET 3 AA2 5 ILE A 316 SER A 326 1 O SER A 317 N PHE A 226 SHEET 4 AA2 5 VAL A 308 ILE A 312 -1 N VAL A 308 O ILE A 320 SHEET 5 AA2 5 VAL A 296 LYS A 299 -1 N ILE A 297 O LEU A 311 SHEET 1 AA3 2 LEU A 266 GLU A 267 0 SHEET 2 AA3 2 ILE A 270 LEU A 271 -1 O ILE A 270 N GLU A 267 LINK NE2 HIS A 390 ZN ZN A 601 1555 1555 1.99 LINK SG CYS A 396 ZN ZN A 601 1555 1555 2.24 LINK SG CYS A 397 ZN ZN A 601 1555 1555 2.14 LINK SG CYS A 404 ZN ZN A 601 1555 1555 2.22 CISPEP 1 SER A 305 PRO A 306 0 9.23 CRYST1 45.355 59.530 162.596 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022048 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016798 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006150 0.00000